Skip to content

CloudTMSRecalls & reported problems

Neurosoft, Ooo · The CloudTMS system is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medications in the current episode. The Cloud TMS stimulator is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD). · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04650075330296), received between Aug 21, 2025 and Aug 21, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Off-Label Use” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Off-Label Use1

Patient problems

  • Convulsion/Seizure1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 21, 2025Off-Label Use; Off-Label Use

    ON (B)(6) 2025, THE CUSTOMER CONTACTED THE AUTHORIZED AGENT'S OFFICE TO TELL THAT SHE EXPERIENCED A SEIZURE WHILE TREATING HERSELF WITH THE MACHINE, USING AN UNKNOWN PROTOCOL THAT, ACCORDING TO HER, WAS DESIGNED BY ONE OF HER FRIENDS. THE CUSTOMER SENT A VIDEO OF THAT INCIDENT, THE VIDEO BEING DATED (B)(6) 2025, SHOWING SHE WAS ADMINISTERING THAT TREATMENT TO HERSELF, WITH NO ONE SEEN IN THE ROOM WITH HER. SHE IS SEEN STANDING UP WITH THE COIL ON HER HEAD AND THEN FALLING DOWN AND GOING OUT OF CAMERA VIEW, SO THERE WAS NO CONFIRMATION BY VIDEO RECORDING, OR BY ANY OBSERVER OF WHAT HAPPENED DURING OR AFTER THE FALL. ON (B)(6) 2025, THE CUSTOMER EMAILED THE AUTHORIZED AGENT TELLING THAT SHE HAD BEEN TAKEN TO THE EMERGENCY ROOM AFTER THE FALL, AND WAS DISCHARGED WITH "SEIZURE AND CONCUSSION PRECAUTIONS", BUT THERE WAS NO MENTION IN HER EMAIL OF ANY EXAM FOR SEIZURES OR EEG RECORDING DURING HER EMERGENCY ROOM VISIT. THE CUSTOMER RETURNED THE MACHINE AND ITS LAPTOP, WHERE IT WAS WITNESSED THAT SHE HAD INSTALLED A TMS PROTOCOL THAT WAS NOT INCLUDED IN HER LAPTOP PRIOR TO SHIPMENT. ONCE THE MACHINE WAS BACK, IT WAS COMPLETELY CHECKED, ITS FUNCTIONING WAS TESTED AND IT WAS FOUND THAT THE D

    Patient problems: Convulsion/Seizure

    MAUDE report 22861152 ↗

Other Transcranial Magnetic Stimulator devices

All Transcranial Magnetic Stimulator devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page